Plunkett Research Online: Lonza Group AG

LONZA GROUP AG (LZAGY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company .....



Lonza Group AG
Ticker: LZAGY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 41 613168111
Fax: 41 613169111
Address: Muenchensteinerstrasse 38
Basel, 4002 Switzerland

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Chemicals Manufacturing
Pharmaceutical Intermediates
Biocides
Materials Research
Active Drug Ingredients
Monoclonal Antibody Drugs
Pharmaceutical Capsules
Specialty Chemicals
Contacts Description
Albert Baehny Chairman of the Board/Director
Dorothee Deuring Director
See More

Auditor: KPMG AG
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Capsugel
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: